MC
Meghana C Dixit
About Meghana C Dixit
Data last updated:
Meghana C Dixit is a Director at Chanre Rheumatology And Immunology Center And Research Private Limited (since 2021). The company operates in Healthcare. Chanre Rheumatology And Immunology Center And Research Private Limited reported revenue of ₹14.17 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 18 Nov 2021 | 2007 | ₹14.17 Cr (FY 2025) | Active |
Board colleagues of Meghana C Dixit
| Name | DIN | Company | Designation |
|---|---|---|---|
| Manasa Chandrashekara Dixit | 09404462 | Chanre Rheumatology And Immunology Center And Research Private Limited | Director |
| Renuka Chandrasekhar | 00396584 | Chanre Rheumatology And Immunology Center And Research Private Limited | Director |
| Srikantiah Chandrashekara | 00396550 | Chanre Rheumatology And Immunology Center And Research Private Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Meghana C Dixit
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Meghana C Dixit
Meghana C Dixit currently holds 1 directorship: Chanre Rheumatology And Immunology Center And Research Private Limited (Director, since 18 Nov 2021, revenue ₹14.17 Cr (FY 2025)).
Meghana C Dixit was first appointed on 18 Nov 2021 as Director at Chanre Rheumatology And Immunology Center And Research Private Limited.
The current boards of Meghana C Dixit's companies include Manasa Chandrashekara Dixit (Chanre Rheumatology And Immunology Center And Research Private Limited), Renuka Chandrasekhar (Chanre Rheumatology And Immunology Center And Research Private Limited), Srikantiah Chandrashekara (Chanre Rheumatology And Immunology Center And Research Private Limited).